The Role of Artificial Intelligence in Revolutionizing
OA: green
CC0
AI-generated summary
This review synthesizes 2020–2026 research demonstrating that AI-driven analysis of miRNA signatures and protein panels achieves high-accuracy, non-invasive diagnosis of endometriosis, potentially reducing diagnostic delays.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The diagnosis of endometriosis has historically been hampered by an average diagnostic delay of seven to ten years, owing largely to the field’s reliance on invasive surgical laparoscopy as the “gold standard.” The integration of artificial intelligence (AI) and machine learning (ML) into clinical pathology, however, is now catalyzing a paradigm shift toward non-invasive, precision diagnostics. This report synthesizes research published between 2020 and 2026, highlighting the emergence of high-accuracy diagnostic tools built on microRNA (miRNA) signatures, plasma protein panels, and genomic markers. Key findings include the validation of blood- and saliva-based miRNA signatures achieving area under the curve (AUC) values exceeding 0.95, rivaling the accuracy of surgical diagnosis. AI methodologies including Random Forest, eXtreme Gradient Boosting (XGBoost), and support vector machines (SVM) have identified novel biomarkers such as PNMA2, LRP1, and WISP2/CCN5. These advances promise not only to shorten diagnostic latency but also to enable molecular stratification, supporting more personalized treatment strategies. Challenges remain in clinical standardizatio
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-10-08T06:07:16.286025+00:00
License: CC0
· commercial use OK